Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature.

CONCLUSION: Although only 3 cases are reported, the exceptional results and the absence of side effects observed strongly warrant future trials to investigate the role intraperitoneal chemotherapy can have both as palliative treatment of refractory ascites and as salvage therapy in advanced endometrial cancer. PMID: 31597138 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31597138?dopt=Abstract

Source: Oncology - October 8, 2019 Category: Cancer & Oncology Authors: Perniola G, Santangelo G, Palaia I, Musella A, Tomao F, Di Donato V, Muzii L, Benedetti Panici P Tags: Oncology Source Type: research